iBio
IBIO
16 hedge funds and large institutions have $1.01M invested in iBio in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
166% more capital inflows, than outflows
Capital inflows: $88.7K | Capital outflows: $33.3K
0.04% more ownership
Funds ownership: 3.37% → 3.41% (+0.04%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
6% less funds holding
Funds holding: 17 → 16 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
+$37.1K |
| 2 |
Two Sigma Securities
New York
|
+$29K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.1K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.22K |
| 5 |
BlackRock
New York
|
+$1.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.3K |
IBIO Hedge Fund Activity: Q3 2017 in Review
16 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2017, worth a combined $1.01M — down 13% from $1.16M a quarter earlier.
Fund positioning in IBIO was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $37.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $22K sold.
- 16 institutional investors held iBio (IBIO) as of Q3 2017, down from 17 in Q2 2017.
- Funds reported $1.01M of iBio stock for Q3 2017, down 13% quarter-over-quarter.
- 1 fund opened new iBio positions in Q3 2017 and 1 closed out, a net change of 0 holders.
- The largest iBio buyer in Q3 2017 was Virtu Financial, an estimated $37.1K added.
- The largest iBio seller in Q3 2017 was Citadel Advisors, an estimated $22K sold.
Based on aggregated 13F filings for Q3 2017.